27. PULMONARY CRYPTOCOCCOSIS IN A IMMUNOCOMPETENT PATIENT DIFFERENTIAL DIAGNOSIS FROM PULMONARY TUBERCULOSIS: CASE REPORT IN NATIONAL LUNG HOSPITAL IN 2023
Main Article Content
Abstract
Introduction: Pulmonary cryptococcosis (PC) describes an invasive lung mycosis caused by Cryptococcus neoformans or Cryptococcus gattii complex. PC is a very rare form of pneumonia, which is seldom seen among immunocompetent patients, and may be misdiagnosed as pulmonary tuberculosis, leading to a delay in therapy.
Objective: This article aims to report in detail a case of PC in a healthy person, diagnosed based on CT-guided lung biopsy and histopathology. Cases contribute to scientific data, and share experiences about the diagnostic and treatment process.
Case report: A 53-year-old female healthy subject was admitted to Hightech on-demand treatment center of National Lung Hospital because of cough and shortness of breath for 20 days. This patient had the complaints of irritating productive cough, chest tightness and a broad-spectrum antibiotic treatment was ineffective. Although the AFB sputum test was positive, a CT-guided lung biopsy was performed to and PC was diagnosed. Patient was treated by intravenous fluconazole for two weeks. The patient’s follow-up was performed, and we have seen the patient recovered and doing well.
Discussion: Discuss clinical imaging features, differential diagnosis with pulmonary tuberculosis, and the role of biopsy and histopathology. Emphasize the importance of accurate diagnosis and monitoring of treatment response
Conclusion: Summarizing the insights from the case report and discussion, the conclusion emphasizes the importance of accurate diagnosis and effective treatment strategies for PC. Further research and long-term follow-up are encouraged to gain a deeper understanding of this uncommon condition.
Article Details
Keywords
Pulmonary cryptococcosis, pulmonary tuberculosis, CT-guided lung biopsy
References
J Fungi (Basel), 8 (11), 2022.
[2] E. Galanis et al., Epidemiology of Cryptococcus
gattii, British Columbia, Canada, 1999-2007.
Emerg Infect Dis, 16 (2), 2010, 251-257.
[3] S. Kohno et al., Clinical features of pulmonary
cryptococcosis in non-HIV patients in Japan. J
Infect Chemother, 21 (1), 2015, 23-30.
[4] K. D. Song et al., Pulmonary cryptococcosis:
Imaging findings in 23 non-AIDS patients. Korean J
Radiol, 11 (4), 2010, 407-416.
[5] F. Ye, et al., Retrospective analysis of 76 immu-
nocompetent patients with primary pulmonary
cryptococcosis. Lung, 190 (3), 2012, 339-346.
[6] I. Nakatudde et al., It is not always Tuberculosis!
A case of pulmonary cryptococcosis in an immu-
nocompetent child in Uganda. Afr Health Sci, 21
(3), 2021, 990-994.
[7] E. P. Oliveira et al., Tuberculosis and neurocry-
ptococcosis by Cryptococcus neoformans molecular
type VNI in A non-HIV patient: A comorbidities case
report. J Mycol Med, 32 (1), 2022,101213.
[8] C. C. Chang et al., Pulmonary Cryptococcosis.
Semin Respir Crit Care Med, 36 (5), 2015, 681-691.
[9] Bộ Y tế, Hướng dẫn chẩn đoán, điều trị và dự
phòng bệnh lao, 44-47, 2018.
[10] A. Manhire et al., Guidelines for radiologically
guided lung biopsy. Thorax, 58 (11), 2003, 920-
936.
[11] S. H. Lu et al., [Clinicopathological analysis of
primary pulmonary cryptococcosis]. Zhonghua
Jie He He Hu Xi Za Zhi, 32 (6), 2009, 430-433.
[12] J. R. Perfect et al., Clinical practice guidelines
for the management of cryptococcal disease:
2010 update by the infectious diseases society of
america. Clin Infect Dis, 50 (3), 2010, 291-322.
[13] A. H. Limper et al., An official American Thoracic
Society statement: Treatment of fungal
infections in adult pulmonary and critical care
patients. Am J Respir Crit Care Med, 183 (1),
2011, 96-128.